| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 08/26/2004 | CA2516118A1 Substituted n-arylheterocycles, method for production and use thereof as medicaments |
| 08/26/2004 | CA2515838A1 Piperidine-benzenesulfonamide derivatives |
| 08/26/2004 | CA2515130A1 Method of stabilizing lansoprazole |
| 08/26/2004 | CA2514382A1 Pyrazoles and methods of making and using the same |
| 08/26/2004 | CA2514363A1 Substituted azole derivatives as therapeutic agents |
| 08/26/2004 | CA2514105A1 Chemical derivatives binding very specifically with g-quadruplex dna structures and use thereof as a specific anti-cancer agent |
| 08/26/2004 | CA2513716A1 Piperazine-2-carboxamide derivatives |
| 08/26/2004 | CA2513613A1 Indolylmaleimide derivatives |
| 08/25/2004 | EP1449841A1 New fungicidal compounds |
| 08/25/2004 | EP1449835A2 Alpha-substituted pyrimidine-thioalkyl and alkylether compounds |
| 08/25/2004 | EP1449834A2 Inhibition of raf kinase using symmetrical and unsymmetrical substituted diphenyl ureas |
| 08/25/2004 | EP1449529A1 Protein Kinase C Inhibitors |
| 08/25/2004 | EP1448566A2 Chemokine receptor antagonists and methods of use thereof |
| 08/25/2004 | EP1448564A2 Substituted indolizine-like compounds and methods of use |
| 08/25/2004 | EP1448557A2 Heteroindanes: a new class of potent cannabimimetic ligands |
| 08/25/2004 | EP1448556A1 Heteroaryl amines as glycogen synthase kinase 3beta inhibitors (gsk3 inhibitors) |
| 08/25/2004 | EP1448555A1 Pyridine and pyrimidine derivatives |
| 08/25/2004 | EP1448554A1 Propylcarbamate derivatives as inhibitors of serine and cysteine proteases |
| 08/25/2004 | EP1448553A1 N-heterocyclyl hydrazides as neurotrophic agents |
| 08/25/2004 | EP1448551A1 Processes for the preparation of substituted bicyclic derivatives for the treatment of abnormal cell growth |
| 08/25/2004 | EP1448550A1 Nitrogenous tetrahydropyridyl-alkyl-heterocycles with tnf activity |
| 08/25/2004 | EP1448549A1 Delta1-pyrrolines |
| 08/25/2004 | EP1448548A1 Piperidine derivatives and their use as modulators of chemokine receptor activity (especially ccr5) |
| 08/25/2004 | EP1448547A1 Pyridine derivatives as nmda receptor ligands |
| 08/25/2004 | EP1448534A1 6-membered unsaturated heterocyclic compounds useful for selective inhibition ofthe coagulation cascade |
| 08/25/2004 | EP1448532A1 5-phenylpyrimidines, agents comprising the same, method for production and use thereof |
| 08/25/2004 | EP1448531A1 3-cyanoquinolines as inhibitors of egf-r and her2 kinases |
| 08/25/2004 | EP1448528A2 Preparation of pharmaceutical salts of 4((z)-(4-bromophenyl)(ethoxyimino)methyl)-1'-((2,4-dimethyl-1-oxido-3-pyridinyl)carbonyl)-4'-methyl-1,4'bipiperidine as ccr5-antagonists for the treatment of aids and related hiv infections |
| 08/25/2004 | EP1448526A1 Piperidine-based mch antagonists for treatment of obesity and cns disorders |
| 08/25/2004 | EP1448525A1 Novel piperidine derivatives as modulators of chemokine receptors |
| 08/25/2004 | EP1448524A1 Piperidine derivatives and their use as modulators of chemokine receptor activity (especially ccr5) |
| 08/25/2004 | EP1448523A1 Heterocyclic compounds and methods of use |
| 08/25/2004 | EP1448521A1 Derivatives of andrimide and moiramide b having antibacterial properties |
| 08/25/2004 | EP1448520A1 Benzamide derivatives, processes for their preparation, and their pharmaceutical use |
| 08/25/2004 | EP1448513A1 Biphenyl-derivatives as p38-kinase inhibitors |
| 08/25/2004 | EP1448200A2 (4-phenyl)piperidin-3-yl-phenylcarboxylate derivatives and related compounds as beta-secretase inhibitors for the treatment of alzheimer's disease |
| 08/25/2004 | EP1448199A1 Benzimidazoles useful as protein kinase inhibitors |
| 08/25/2004 | EP1448193A1 Therapeutic compounds for treating dyslipidemic conditions |
| 08/25/2004 | EP1448176A2 Utilization of inhibitors of rho-kinases for stimulating nerve growth, inhibiting scar tissue formation and/or reducing a secondary lesion |
| 08/25/2004 | EP1448155A1 Use of at least one abl, kit and/or platelet-derived growth factor receptor tyrosine kinases inhibitor for treating hair depigmentation |
| 08/25/2004 | EP1278728B1 Pyrrolidine and piperidine derivatives and their use for the treatment of neurodegenerative disorders |
| 08/25/2004 | EP1270555B1 Method for oxidizing a thioether group into a sulfoxide group |
| 08/25/2004 | EP1159271B1 Antiviral 2,4-pyrimidinedione derivatives and process for the preparation thereof |
| 08/25/2004 | EP1156044B1 6-substituted heteroquinolinecarboxylic acid derivatives and addition salts thereof and processes for the preparation of both |
| 08/25/2004 | EP1150977B1 Phenyl urea and phenyl thiourea derivatives as orexin receptor antagonists |
| 08/25/2004 | EP1098882B1 A process for preparing benzocycloheptapyridin-11-ones |
| 08/25/2004 | EP1087963B1 Inhibitors of glycogen synthase kinase 3 |
| 08/25/2004 | CN1524080A Phthalatyinone-piperidino-derivatives as pde4 inhibitors |
| 08/25/2004 | CN1524079A Novel sulfamides and their use as endothelin receptor antagonists |
| 08/25/2004 | CN1524077A Therapeutic chroman compounds |
| 08/25/2004 | CN1523989A Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
| 08/25/2004 | CN1523988A Use of nk-1 receptor antagonists for the treatment of brain, spinal or nerve injury |
| 08/25/2004 | CN1523015A 2-amino-6-(2-substituted-4-phenoxy)-substituted-pyridines |
| 08/25/2004 | CN1522701A Epoxy-steroidal aldosterone antagonist and angiotensin ii antagonist combination therapy |
| 08/25/2004 | CN1163488C Process for preparing insecticide |
| 08/25/2004 | CN1163484C 4-Aroyl-Piperidin-CCR-3 receptor antagonist III |
| 08/25/2004 | CN1163477C Substituted beta-alanine |
| 08/25/2004 | CN1163363C Optical recording media |
| 08/25/2004 | CN1163224C Drugs for improving vesical excretory capacity |
| 08/24/2004 | US6780996 Process for the preparation of 7-substituted-3 quinolinecarbonitriles |
| 08/24/2004 | US6780994 Phthalimido arylpiperazines useful in the treatment of benign prostatic hyperplasia |
| 08/24/2004 | US6780882 Substituted benzimidazole dosage forms and method of using same |
| 08/24/2004 | US6780878 Antithrombotic amides |
| 08/24/2004 | US6780877 Acid addition salt of optically active piperidine compound and process for preparing the same |
| 08/24/2004 | US6780876 Composition for keeping away vermin |
| 08/24/2004 | US6780875 Quinoline-4-carboxamide derivatives as NK-3 and NK-2 receptor antagonists |
| 08/24/2004 | US6780870 Treatment of the pain (both chronic and acute), fever and inflammation of a variety of conditions and diseases mediated by cox-2 |
| 08/24/2004 | US6780868 Treatment of myocardial or peripheral ischaemia, cardiac insufficiency or pulmonary arterial hypertension |
| 08/24/2004 | US6780864 Piperazine and piperidine compounds |
| 08/24/2004 | US6780857 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity |
| 08/24/2004 | CA2313122C Bicycliccarbonyl indole compounds as anti-inflammatory/analgesic agents |
| 08/24/2004 | CA2293711C Benzo(5,6)cycloheptapyridine compounds useful as farnesyl protein transferase inhibitors |
| 08/24/2004 | CA2285733C Process for preparation of pyrazolo[4,3-d]pyrimidin-7-ones and intermediates thereof |
| 08/24/2004 | CA2143610C Use of norastemizole for the treatment of allergic disorders |
| 08/19/2004 | WO2004070352A2 Methods, mixtures, kits and compositions pertaining to analyte determination |
| 08/19/2004 | WO2004070050A2 Cyclic urea derivatives, preparation method thereof and pharmaceutical use of same as kinase inhibitors |
| 08/19/2004 | WO2004069831A1 Tricyclic compounds useful for the treatment of inflammatory and allergic disorders: process for their preparation |
| 08/19/2004 | WO2004069830A1 Triazole compounds and the therapeutic use thereof |
| 08/19/2004 | WO2004069829A1 (2s)-2-((pyrimidin-4-yl)amino)-4-methylpentanoic acid aminoethylamid derivatives as il-8 receptor modulators for the treatment of atherosclerosis and rheumatoid arthritis |
| 08/19/2004 | WO2004069828A1 Piperidine compound and medicinal use thereof |
| 08/19/2004 | WO2004069827A1 Quinoline derivatives and use thereof as antitumor agents |
| 08/19/2004 | WO2004069826A1 Malonamide derivatives as gamma-secretase inhibitors |
| 08/19/2004 | WO2004069824A1 Pyrazole derivative |
| 08/19/2004 | WO2004069823A1 Inhibitors of histone deacetylase |
| 08/19/2004 | WO2004069814A1 Amino 1, 3, 5-triazines n-substituted with chiral bicyclic radicals, process for their preparation, compositions thereof and their use as herbicides and plant growth regulators |
| 08/19/2004 | WO2004069798A1 Melanin-concentrating hormone receptor antagonists containing piperidine derivatives as the active ingredient |
| 08/19/2004 | WO2004069794A2 New arylpiperazinyl compounds |
| 08/19/2004 | WO2004069793A2 Novel 2-substituted cyclic amines as calcium sensing receptor modulators |
| 08/19/2004 | WO2004069792A2 Quinoline-derived amide modulators of vanilloid vr1 receptor |
| 08/19/2004 | WO2004069394A2 Synthetic method for direct arylation of heterocyclic arenes |
| 08/19/2004 | WO2004069250A1 3-cyano-quinoline derivatives as non-receptor tyrosine kinase inhibitors |
| 08/19/2004 | WO2004069249A1 3-cyano-quinoline derivatives as non-receptor tyrosine kinase inhibitors |
| 08/19/2004 | WO2004069160A2 Chemical compounds |
| 08/19/2004 | WO2004069158A2 Substituted pyrazoles, compositions containing such compounds and methods of use |
| 08/19/2004 | WO2004069139A2 4-aminopyrimidin-5-yl-methanone derivatives for inhibition of cdk4 activity |
| 08/19/2004 | WO2004062571A3 Substantially pure cilostazol and processes for making same |
| 08/19/2004 | WO2004058705A3 Inhibitors of the binding of chemokines i-tac or sdf-1 to the ccxckr2 receptor |
| 08/19/2004 | WO2004056365A3 Derivatives of aryl-quinazoline/aryl-2amino-phenyl methanone which promote the release of parathyroid hormone |
| 08/19/2004 | WO2004052371A3 Cyclic quinoline compounds for use in mch receptor related disorders |
| 08/19/2004 | WO2004052370A3 Quinoline compounds for use in mch receptor related disorders |